PGNY
Progyny, Inc. Health Care Services-Misc Health & Allied Services, NEC Russell 3000
$29.19Close
$2.4BMarket cap
$16.30 – $32.3652-week range
Nov 4, 2026Next report · after the close
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 80 · stronger than 80% of stocks over 12 months
- Volume drying up last 10 days 28% under the 50-day average
- Earnings growing EPS +79% year on year, faster than the quarter before (+9 pts)
Cautions
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
10%
1wk
up 0.8%
price change
1mo
up 15.9%
price change
12-month return
up 57%
market up 11% ·
its own up 42%
F-score
8 / 9
Exceptional
Altman Z″
7.14
Low risk
P/E
41.6×
price / earnings
PEG
2.89
P/E / EPS growth
P/B
4.7×
price / book
Earnings yield
up 3.7%
EBIT / enterprise value
Cheaper than
57%
of the market · around average
Revenue growth
up 10%
year on year
EPS growth
up 79%
latest quarter · +9 pts
Sales growth
up 5%
latest quarter · +4 pts
ROE
up 12%
return on equity
Free cash margin
up 15%
$191.8M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
-1.2×
net cash
Interest cover
—EBIT / interest
Piotroski tests
- short-term liquidity weakened
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- no new shares issued
- gross margin widened
- assets working harder
Repair signals
- Gross margin 21.7% → 23.6%
Trade setup
ATR%
3.0%
$0.87 a day · 2×ATR $27.46
RS
80 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.35
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 8 of 8
Screen verdict
-
Stage 2 Leader in mixed conditions
- RS 80
- Trend 8/8
- Off 12-month high 10%
- EPS growth +79% (accel +9 pts)
- Sales growth +5% (accel +4 pts)
- Altman Z″ 7.14 (low risk)
-
Repair to Leader in mixed conditions
- Fell 43% within the year
- 79% above the low
- Trend 8/8, above its 50-day, 200-day rising
- F-score 8/9
- Cheaper than 57%
- Altman Z″ 7.14 (low risk)
- Relative strength still slipping (-49 pts, 3m vs 12m)
- RS 80
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026-11% vs market2 sessions after results
Financials
- Gross 24%
- Net 5%
- Free cash 15%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $344.9M | $500.6M | $786.9M | $1.1B | $1.2B | $1.3B |
| Gross margin | 20% | 22% | 21% | 22% | 22% | 24% |
| Operating income | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | $85.3M |
| Net income | $46.5M | $65.8M | $30.4M | $62.0M | $54.3M | $58.5M |
| Net margin | 13% | 13% | 4% | 6% | 5% | 5% |
| Earnings per share | $0.47 | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
| Free cash flow | $35.2M | $23.9M | $77.2M | $185.2M | $173.7M | $191.8M |
| Free cash margin | 10% | 5% | 10% | 17% | 15% | 15% |
| Cash | $70.3M | $91.4M | $120.1M | $97.3M | $162.3M | $112.2M |
| Shareholders' equity | $166.9M | $251.8M | $377.0M | $553.4M | $422.1M | $516.0M |
| Shares outstanding | 87.05m | 91.09m | 93.30m | 96.35m | 85.31m | 83.37m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Feb 27, 2026 | Annual ↗ | Dec 31, 2025 | 58d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Mar 3, 2025 | Annual ↗ | Dec 31, 2024 | 62d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 7, 2024 | Quarterly ↗ | Jun 30, 2024 | 38d |
| May 10, 2024 | Quarterly ↗ | Mar 31, 2024 | 40d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results · Regulation FD ↗ |
| May 27, 2026 | Charter or bylaws · Shareholder vote ↗ |
| May 26, 2026 | Other events ↗ |
| May 7, 2026 | Results · Regulation FD ↗ |
| Mar 13, 2026 | Other events ↗ |
| Feb 26, 2026 | Results · Regulation FD ↗ |
| Jan 12, 2026 | Results ↗ |
| Dec 17, 2025 | Director or officer change ↗ |
| Nov 6, 2025 | Results · Regulation FD ↗ |
| Aug 7, 2025 | Results ↗ |
| Jul 8, 2025 | Material agreement · Results · New obligation ↗ |
| May 28, 2025 | Shareholder vote ↗ |